Showing 1 posts of 1 posts found.

Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone

March 24, 2020
Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma

Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …

Latest content